Evaluasi Kejadian Ikutan Pasca Imunisasi pada Peserta Vaksinasi di Puskesmas Teluk Dalam, Tenggarong Seberang

Evaluation of Adverse Events Following Immunization in Vaccination Participants at Teluk Dalam Tenggarong Seberang Community Health Center

Authors

  • Renaldi Adi Saputra Laboratorium Penelitian dan Pengembangan Kefarmasian “Farmaka Tropis”, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia
  • Niken Indriyanti Laboratorium Penelitian dan Pengembangan Kefarmasian "Farmaka Tropis"?, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia
  • Dewi Rahmawati Laboratorium Penelitian dan Pengembangan Kefarmasian "Farmaka Tropis"?, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia

DOI:

https://doi.org/10.25026/mpc.v15i1.636

References

[1] https://covid.cdc.gov/covid-data-tracker/#global-vaccinations (Diakses Pada 23 Mei 2022)

[2] https://covid19.go.id/artikel/2022/05/21/situasi-covid-19-di-indonesia-update-21-mei-2022 (Diakses Pada 23 Mei 2022)

[3] https://covid19.go.id/index.php/artikel/2021/12/28/10-vaksin-covid-19-yang-sudah-dapatkan-izin-penggunaan-darurat-dari-badan-pom (Diakses Pada 23 Mei 2022)

[4] A. Riad, A. Pokorná, 2021. Prevalence of covid-19 vaccine side effects among healthcare workers in the Czech Republic,” J. Clin. Med., vol. 10, no. 7, pp. 1–18, doi: 10.3390/jcm10071428.

[5] R. Desnita, V. S. Sapardi, 2022. Kejadian Ikutan Pasca Imunisasi ( KIPI ) Vaksin Covid-19 Dosis Pertama dan Kedua Adverse Events After Immunization ( AEFI ) First and Second Dose of Covid-19 Vaccine, vol. 6, no. 1, pp. 20–26.

[6] Supangat, E. N. Sakinah, 2021. COVID-19 Vaccines Programs: adverse events following immunization (AEFI) among medical Clerkship Student in Jember, Indonesia,” BMC Pharmacol. Toxicol., vol. 22, no. 1, pp. 1–7, doi: 10.1186/s40360-021-00528-4.

[7] R. Urakawa, E. T. Isomura, 2022. Impact of age, sex and medical history on adverse reactions to the first and second dose of BNT162b2 mRNA COVID-19 vaccine in Japan: a cross-sectional study, BMC Infect. Dis., vol. 22, no. 1, pp. 1–8, doi: 10.1186/s12879-022-07175-y.

[8] A. Pormohammad et al., 2021. Efficacy and safety of covid-19 vaccines: A systematic review and meta-analysis of randomized clinical trials, Vaccines, vol. 9, no. 5, pp. 1–21, 2021, doi: 10.3390/vaccines9050467.

[9] J. Sprent, C. King, 2021. COVID-19 vaccine side effects: The positives about feeling bad, Sci. Immunol., vol. 6, no. 60, pp. 2–4, 2021, doi: 10.1126/sciimmunol.abj9256.

[10] Meo SA, Bukhari IA, 2021. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines, Eur. Rev. Med. Pharmacol. Sci., vol. 25, no. 3, pp. 1663–1669.

Downloads

Published

2022-05-31

How to Cite

Saputra, R. A., Indriyanti, N., & Rahmawati, D. (2022). Evaluasi Kejadian Ikutan Pasca Imunisasi pada Peserta Vaksinasi di Puskesmas Teluk Dalam, Tenggarong Seberang: Evaluation of Adverse Events Following Immunization in Vaccination Participants at Teluk Dalam Tenggarong Seberang Community Health Center. Proceeding of Mulawarman Pharmaceuticals Conferences, 15(1), 160–164. https://doi.org/10.25026/mpc.v15i1.636

Most read articles by the same author(s)

<< < 1 2 3 4 5 6 7 > >>